Abstract
Nef is a regulatory protein expressed exclusively by HIV-1 / 2 and SIV. It is critical for the optimal viral infectivity and for the destruction of the host immune system. This renders Nef a rather attractive therapeutic target. The most affordable point(s) of attack for effective anti-Nef therapeutic strategies can be individuated on the basis of a detailed knowledge of the mechanisms underlying the Nef induced enhancement of infectivity. However, the emerging picture still appears rather complex and not always coherent, so that additional, intensive endeavours in basic research are required for an effective exploitation of the Nef induced increase of infectivity as a therapeutic target.
Keywords: nef, hiv, virus infectivity, anti-viral therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: Targeting the Nef Induced Increase of HIV Infectivity
Volume: 4 Issue: 4
Author(s): Maurizio Federico
Affiliation:
Keywords: nef, hiv, virus infectivity, anti-viral therapy
Abstract: Nef is a regulatory protein expressed exclusively by HIV-1 / 2 and SIV. It is critical for the optimal viral infectivity and for the destruction of the host immune system. This renders Nef a rather attractive therapeutic target. The most affordable point(s) of attack for effective anti-Nef therapeutic strategies can be individuated on the basis of a detailed knowledge of the mechanisms underlying the Nef induced enhancement of infectivity. However, the emerging picture still appears rather complex and not always coherent, so that additional, intensive endeavours in basic research are required for an effective exploitation of the Nef induced increase of infectivity as a therapeutic target.
Export Options
About this article
Cite this article as:
Federico Maurizio, Targeting the Nef Induced Increase of HIV Infectivity, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2004; 4(4) . https://dx.doi.org/10.2174/1568005310404040321
DOI https://dx.doi.org/10.2174/1568005310404040321 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
Related Articles
-
Gender Differences in Cancer-associated Venous Thromboembolism
Current Medicinal Chemistry Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension
Current Medicinal Chemistry Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Epicardial and Intramyocardial Adipose Tissue: The Enemy within
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Contractile Properties of Airway Smooth Muscle: How their Defects can be Linked to Asthmatic Airway Hyperresponsiveness?
Current Respiratory Medicine Reviews The Effects of Italian Mediterranean Organic Diet (IMOD) on Health Status
Current Pharmaceutical Design Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer’s Disease
Current Alzheimer Research The Etiology of Hypertension in the Metabolic Syndrome Part Two: The Gene-Environment Interaction
Current Vascular Pharmacology PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals
Current Drug Delivery Recent Patents on Nonlamellar Liquid Crystalline Lipid Phases in Drug Delivery
Recent Patents on Drug Delivery & Formulation Vasostatins and Negative Inotropy in Vertebrate Hearts
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Current Medicinal Chemistry Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis
Current Drug Safety Applications of Circadian Metabolomics
Current Metabolomics Fungal Pathogens Research: Novel and Improved Molecular Approaches for the Discovery of Antifungal Drug Targets
Current Drug Targets Insulin Therapy for Improving Cardiac Surgical Outcomes
Current Drug Targets Histidine Rich Glycoprotein, an Endogenous Regulator of Macrophage and Endothelial Biology
Current Angiogenesis (Discontinued) The Discrepancy between Gross Features and Chemical Compositions in Gallbladder Stone: A Descriptive Single Center Study in the United Arab Emirates
New Emirates Medical Journal